Sabine Yerly
- Virology top 0.05%
- HIV Research and Treatment 137
- Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment 117
- HIV/AIDS Research and Interventions 101
- SARS-CoV-2 and COVID-19 Research 16
- COVID-19 Clinical Research Studies 12
- SARS-CoV-2 detection and testing 10
- Epidemiology top 1%
- Emergency Medicine top 1%
- HIV-related health complications and treatments 20
- Hepatology top 2%
- Hepatitis C virus research 19
- Co-authors
- Luc PerrinBernard HirschelLaurent KaiserHuldrych F. GünthardLionel PerrinViktor von WylThomas KlimkaitPhilippe Bürgisser
- Journals
- New England Journal of Medicine (2 papers)The Lancet (2 papers)The Journal of Experimental Medicine (1 paper)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Sabine Yerly
187 papers receiving 7.5k citations
Peers
Comparison fields: 5 of 147
- Virology 5.0k
- Infectious Diseases 5.8k
- Epidemiology 2.1k
- Emergency Medicine 564
- Hepatology 389
Countries citing papers authored by Sabine Yerly
This map shows the geographic impact of Sabine Yerly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Yerly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Yerly more than expected).
Fields of papers citing papers by Sabine Yerly
This network shows the impact of papers produced by Sabine Yerly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Yerly. The network helps show where Sabine Yerly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sabine Yerly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 27 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 6 | |
| 8 | 2020 | 73 | |
| 9 | 2020 | 20 | |
| 10 | 2016 | 39 | |
| 11 | 2014 | 12 | |
| 12 | 2010 | 11 | |
| 13 | 2010 | 23 | |
| 14 | Impact of newly HIV diagnosed individuals on the transmission of drug resistance | 2009 | 0 |
| 15 | Drug resistance in newly HIV diagnosed individuals: transmission rate, clusters and persistence | 2008 | 2 |
| 16 | 2004 | 110 | |
| 17 | 2004 | 29 | |
| 18 | 1999 | 12 | |
| 19 | Switch to an unusual amino acid at codon 215 of the HIV-1 reverse transcriptase gene in seroconverters infected with zidovudine resistant variants. | 1998 | 3 |
| 20 | PREVALENCE DE LA TRANSMISSION DE VIRUS RESISTANT A LA ZIDOVUDINE EN SUISSE | 1996 | 9 |
About Sabine Yerly
Sabine Yerly is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 195 papers that have together received 7.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (137 papers), HIV/AIDS drug development and treatment (117 papers), HIV/AIDS Research and Interventions (101 papers), HIV-related health complications and treatments (20 papers), Hepatitis C virus research (19 papers), SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (12 papers) and SARS-CoV-2 detection and testing (10 papers). The work is most often cited by research in Virology (5.0k citations), Infectious Diseases (5.8k citations) and Epidemiology (2.1k citations). Sabine Yerly has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Luc Perrin, Bernard Hirschel, Laurent Kaiser, Huldrych F. Günthard, Lionel Perrin, Viktor von Wyl, Thomas Klimkait, Philippe Bürgisser, Jürg Böni and Pietro Vernazza. Their work appears in journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.